{

"resourceType": "MedicinalProductIndication",
"id": "example",
"diseaseSymptomProcedure": {
  "coding": [
    {
      "system": "http://ema.europa.eu/example/indicationasdisease-symptom-procedure",
      "code": "Venousthromboembolismprophylaxis"
    }
  ],
  "text": "Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."
},
"comorbidity": [
  {
    "coding": [
      {
        "system": "http://ema.europa.eu/example/comorbidity",
        "code": "Hipsurgery"
      }
    ]
  }
],
"intendedEffect": {
  "coding": [
    {
      "system": "http://ema.europa.eu/example/intendedeffect",
      "code": "PRYLX"
    }
  ]
},
"population": [
  {
    "ageRange": {
      "low": {
        "value": 18,
        "unit": "a"
      }
    }
  }
],
"meta": {
  "tag": [
    {
      "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
      "code": "HTEST",
      "display": "test health data"
    }
  ]
}

}